No Picture
Trading Ideas

How the .400 Batting Average in Baseball Explains Soros’ and Buffett’s Fading Returns

Warren Buffett and George Soros have long been hailed as two of the world’s greatest investors, but their returns have lagged for years.
Today, Nicholas Vardy offers an explanation.

Note from Senior Managing Editor Christina Grieves: Today’s the day! You may have seen me mention recently that Alexander Green has been hard at work on an exciting new project. And today he’s finally ready to share his latest research with you! Click here right now for Alex’s No. 1 microcap stock recommendation.

It is said that two figures are carved into the Mount Rushmore of investing: Warren Buffett and George Soros.
Their investment styles …read more […]

No Picture
Trading Ideas

10 Best Stocks to Buy in 2020 Based on 3 Popular Investment Styles

The best stocks to buy in 2020 depend on your investment style. Different industries and stocks have a wide range of risk-to-reward profiles.
That’s why I’ve broken the list of stocks below into three categories. These stocks give you a good mix of opportunities. Are you looking for steady dividend stocks? Or maybe fast moving penny stocks? How about contrarian stocks during the pandemic?
To start, let’s look at my favorite investment category. The top dividend stocks below have proven track records of rewarding shareholders. Also, if you want to see how your investments can grow each year, check out our free …read more […]

No Picture
Trading Ideas

Moderna Partners With Catalent For First 100 Million Covid-19 Vaccine Doses In Q3

Moderna Inc. (MRNA) said it entered into a collaboration with Catalent (CTLT) for large-scale, commercial manufacturing of its mRNA-based experimental vaccine candidate against the novel coronavirus.As part of the agreement, Catalent will provide vial filling and packaging, as well as additional staffing at its facility for the production of an initial 100 million doses of the vaccine candidate to supply the U.S. market starting in the third quarter of this year. The companies said that they are also in talks to secure capacity for continued production of hundreds of millions of additional doses.The announcement pushed Catalent shares up 3.2% to …read more […]